These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 668735)

  • 21. Renal cell carcinoma: natural history and results of treatment.
    Patel NP; Lavengood RW
    J Urol; 1978 Jun; 119(6):722-6. PubMed ID: 660755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Embolization and subsequent nephrectomy in metastatic renal cell carcinoma.
    Kurth KH; Cinqualbre J; Oliver RT; Schulman CC
    Prog Clin Biol Res; 1984; 153():423-36. PubMed ID: 6206510
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune RNA therapy for renal cell carcinoma: survival and immunologic monitoring.
    Ramming KP; deKernion JB
    Ann Surg; 1977 Oct; 186(4):459-67. PubMed ID: 907390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive versus conservative management of stage IV renal cell carcinoma.
    Klugo RC; Detmers M; Stiles RE; Talley RW; Cerny JC
    J Urol; 1977 Aug; 118(2):244-6. PubMed ID: 894800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current treatment of metastatic renal cell carcinoma with xenogeneic immune ribonucleic acid.
    Richie JP; Steele GD; Wilson RE; Ervin T; Wang BS; Mannick JA
    J Urol; 1984 Feb; 131(2):236-8. PubMed ID: 6199519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinoma?
    Migliari R; Muscas G; Solinas A; Melis M; Ionta MT; Massidda B; Usai E
    J Chemother; 1995 Jun; 7(3):240-5. PubMed ID: 7562021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
    Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
    Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrectomy for metastatic renal cell carcinoma: Indiana University experience.
    Mosharafa A; Koch M; Shalhav A; Gardner T; Logan T; Bihrle R; Foster R
    Urology; 2003 Oct; 62(4):636-40. PubMed ID: 14550433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.
    Negrier S; Maral J; Drevon M; Vinke J; Escudier B; Philip T
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S93-8. PubMed ID: 10685667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
    Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
    J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative prophylactic use of progesterone in renal cell carcinoma.
    Satomi Y; Takai S; Kondo I; Fukushima S; Furuhata A
    J Urol; 1982 Nov; 128(5):919-22. PubMed ID: 6217352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trial of attenuated vaccinia virus AS strain in the treatment of advanced adenocarcinoma. Report on two cases.
    Arakawa S; Hamami G; Umezu K; Kamidono S; Ishigami J; Arakawa S
    J Cancer Res Clin Oncol; 1987; 113(1):95-8. PubMed ID: 3818784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.
    Mickisch GH; Garin A; van Poppel H; de Prijck L; Sylvester R;
    Lancet; 2001 Sep; 358(9286):966-70. PubMed ID: 11583750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma.
    Montie JE; Stewart BH; Straffon RA; Banowsky LH; Hewitt CB; Montague DK
    J Urol; 1977 Mar; 117(3):272-5. PubMed ID: 65479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The timing of immunotherapy and nephrectomy in multimodality treatment of metastatic renal cell carcinoma.
    Bex A; Horenblas S; de Gast GC
    Technol Cancer Res Treat; 2003 Jun; 2(3):205-10. PubMed ID: 12779351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study.
    Galligioni E; Quaia M; Merlo A; Carbone A; Spada A; Favaro D; Santarosa M; Sacco C; Talamini R
    Cancer; 1996 Jun; 77(12):2560-6. PubMed ID: 8640706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma.
    Fallick ML; McDermott DF; LaRock D; Long JP; Atkins MB
    J Urol; 1997 Nov; 158(5):1691-5. PubMed ID: 9334580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCG immunotherapy of metastatic adenocarcinoma of the kidney.
    Eidinger D; Morales A
    Natl Cancer Inst Monogr; 1978 Dec; (49):339-41. PubMed ID: 748790
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant therapy for adenocarcinoma of the kidney: present position and prospects.
    Bloom HJ
    Br J Urol; 1973 Jun; 45(3):237-57. PubMed ID: 4576466
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of metastasizing renal adenocarcinoma with specific plasma transfusion. A controlled trial of the effects on metastases and survival time].
    Pedersen F; Hippe E; Hvidt V; Francis D; Jensen HS; Dybkjaer E; Rasmussen F
    Ugeskr Laeger; 1980 Nov; 142(48):3167-70. PubMed ID: 7003883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.